Overview

EP4-receptor Antagonism and Prostaglandin E2 (PGE2) in a Human Headache Model

Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether EP-4 receptor antagonist can prevent the headache expected during a Prostaglandin E2 infusion.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Danish Headache Center
Treatments:
Dinoprostone